Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Hyperandrogenism 1

Interventions

Cyclophosphamide 2064 Radiotherapy 1984 Cisplatin 1851 Carboplatin 1557 Gemcitabine 1452 Paclitaxel 1320 Bevacizumab 1316 pembrolizumab 1235 Docetaxel 1225 Oxaliplatin 1181 Capecitabine 1173 Fluorouracil 1081 Dexamethasone 979 Magnetic Resonance Spectroscopy 967 Nivolumab 936 Rituximab 928 Drug Therapy 911 Surveys and Questionnaires 898 Doxorubicin 845 Etoposide 843 Radiosurgery 814 Blood Specimen Collection 814 Irinotecan 783 Cytarabine 743 fludarabine 723 Leucovorin 682 Surgical Procedures, Operative 638 Lenalidomide 618 Biopsy 592 fludarabine phosphate 568

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Phenotype × Clear all

NCT02611128 2023-11-02

DENND1A

University of Virginia

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡